Mostrar o rexistro simple do ítem

dc.contributor.authorMadry, Henning
dc.contributor.authorVenkatesan, Jagadeesh Kumar
dc.contributor.authorCarballo-Pedrares, Natalia
dc.contributor.authorRey-Rico, Ana
dc.contributor.authorCucchiarini, Magali
dc.date.accessioned2020-10-21T11:34:03Z
dc.date.available2020-10-21T11:34:03Z
dc.date.issued2020-09-29
dc.identifier.citationMadry, H.; Venkatesan, J.K.; Carballo-Pedrares, N.; Rey-Rico, A.; Cucchiarini, M. Scaffold-Mediated Gene Delivery for Osteochondral Repair. Pharmaceutics 2020, 12, 930. https://doi.org/10.3390/pharmaceutics12100930es_ES
dc.identifier.issn1999-4923
dc.identifier.urihttp://hdl.handle.net/2183/26494
dc.description.abstract[Abstract] Osteochondral defects involve both the articular cartilage and the underlying subchondral bone. If left untreated, they may lead to osteoarthritis. Advanced biomaterial-guided delivery of gene vectors has recently emerged as an attractive therapeutic concept for osteochondral repair. The goal of this review is to provide an overview of the variety of biomaterials employed as nonviral or viral gene carriers for osteochondral repair approaches both in vitro and in vivo, including hydrogels, solid scaffolds, and hybrid materials. The data show that a site-specific delivery of therapeutic gene vectors in the context of acellular or cellular strategies allows for a spatial and temporal control of osteochondral neotissue composition in vitro. In vivo, implantation of acellular hydrogels loaded with nonviral or viral vectors has been reported to significantly improve osteochondral repair in translational defect models. These advances support the concept of scaffold-mediated gene delivery for osteochondral repair.es_ES
dc.description.sponsorshipThis research was funded by the Deutsche Forschungsgemeinschaft (DFG VE 1099/1-1 to JKV, HM, and MC), the Ministerio de Ciencia e Innovación (RTI2018-099389-A-100 to A.R.-R.), and the Ministerio de Ciencia e Innovación for a Ramón y Cajal Fellowship (RYC2018-025617-I to A.R.-R.).
dc.description.sponsorshipDeutsche Forschungsgemeinschaft; DFG VE 1099/1-1
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-099389-A-I00/ES/CRIOGELES ACTIVADOS POR GENES PARA REPARACION DE CARTILAGO
dc.relationinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2018-025617-I/ES/
dc.relation.urihttps://doi.org/10.3390/pharmaceutics12100930es_ES
dc.rightsAtribución 4.0 Internacional (CC BY 4.0)es_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectOsteochondral repaires_ES
dc.subjectGene therapyes_ES
dc.subjectTissue engineeringes_ES
dc.subjectControlled deliveryes_ES
dc.titleScaffold-Mediated Gene Delivery for Osteochondral Repaires_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitlePharmaceuticses_ES
UDC.volume12es_ES
UDC.issue10es_ES
UDC.startPage930es_ES
dc.identifier.doi10.3390/pharmaceutics12100930


Ficheiros no ítem

Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem